Press release
Global Cerebrospinal Fluid (CSF) Management Market Is Expected To Reach US$ 1,897.5 Mn By 2024
The latest market report published by Credence Research, Inc. “Global Cerebrospinal Fluid (CSF) Management Market- Growth, Future Prospects and Competitive Analysis, 2016 - 2024” the Global Cerebrospinal Fluid (CSF) Management market was valued at US$ 1,152.1Mn in terms of valuein 2015, and is expected to reach USD 1,897.5Mn by 2024, expanding at a CAGR of 5.7% - from 2016 to 2024.Browse the full report Global Cerebrospinal Fluid (CSF) Management Market- Growth, Future Prospects and Competitive Analysis, 2016 – 2024 report at http://www.credenceresearch.com/report/csf-cerebrospinal-fluid-management-market
Market Insights
Cerebrospinal fluid (CSF) is a clear and colorless fluid surroundings the brain and spinal cord. Primary function of CSF is to provide mechanical support and to maintain stable environment in central nervous system by circulating nutrients and removing waste products. The total volume of cerebrospinal fluid in the adult ranges from 140 to 260 ml. - Hydrocephalous is condition in which there is an excess accumulation of cerebrospinal fluid in the brain. Disturbance in absorption and production of cerebrospinal fluid results in abnormal accumulation of cerebrospinal fluid inside the central nervous system. This excess fluid apply pressure on the brain, damaging the brain tissue and resulting in impairments in brain function. About 1 to 2 of every 1,000 new babies are born with hydrocephalus. Hydrocephalus can occur at any age but it is more common in geriatrics and infants.
Global cerebrospinal fluid management market can be segmented on the basis of treatment type. The two treatment options available to treat hydrocephalus are shunt insertion and CSF drainage procedures. Shunt insertion is the most common and primary procedure used to treat hydrocephalus. Shunt is a mechanical device used to divert excess fluid from the brain to another part of the body. CSF drainage procedure is performed as an alternative to shunt insertion procedure. In this procedure, a pathway is created for CSF to flow within the cavities in the brain, by creating hole/ opening at the bottom of ventricle. Currently shunt insertion market hold the largest share in global CSF management market as it is more accurate treatment. The risk associated with CSF shunts such as it leads to post-surgical infection by patient’s own skin organisms. Also the factors such as high cost of surgery and availability of CSF shunts can hinder the growth of the CSF management market. CSF drainage procedure is more cost effective treatment and is anticipated to grow further during the forecast period 2016-2024.
Download Sample Report @ http://www.credenceresearch.com/sample-request/58369
North America was observed as the largest market for cerebrospinal fluid management. Rapid technological innovations, growing demand for minimally invasive surgeries, acceptance of new approaches for treatment would further drive the market growth in this region. Asia Pacific was found second largest market in global CSF management market. In Asia Pacific region market growth is driven by economic development and funding by the government agencies and private organizations.
Market Competition Assessment:
The CSF management market is observed as the most competitive and comprises of large number of players. However, currently market is dominated by few players such as Sophysa S.A., Spiegelberg GmbH & Co. KG, BeckerSmith Medical, Inc., DePuy Synthes (a J & J Company), Medtronic plc., Integra LifeSciences Holding Corp., Moller Medical GmbH, B. Braun Melsungen AG and others.
Browse the full report at http://www.credenceresearch.com/report/csf-cerebrospinal-fluid-management-market
Key Market Movements:
Factors such as economic development, improvement in healthcare infrastructure, introduction of new technologies would further drive the CSF management market during forecast period.
Increase in incidence of neurological diseases among the geriatric population, funding by the government agencies and private organizations are the key growth driver for the CSF management market.
Factors such as high cost of surgery and availability of CSF shunts, post-surgical infection associated with shunt insertion surgery can hinder the growth of the CSF management market.
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Company Name: Credence Research, Inc
Contact Person: Chris Smith, Global Sales Manager
Email: sales@credenceresearch.com
Phone: +1-800-361-8290
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
City: SAN JOSE
State: California
Country: United States
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Cerebrospinal Fluid (CSF) Management Market Is Expected To Reach US$ 1,897.5 Mn By 2024 here
News-ID: 477388 • Views: …
More Releases from credence research

Pharmacy Market Size, Growth | Industry Report, 2023-2032
The latest market report published by Credence Research, Inc. The demand for the US Retail Pharmacy Market, valued at USD 569.79 Billion in 2023, is projected to soar to USD 948.80 Billion by 2032, marking a robust compound annual growth rate (CAGR) of 5.76% during the period from 2024 to 2032.
The US retail pharmacy market stands as a cornerstone of the nation's healthcare infrastructure, serving as the frontline for patient…

Medical Headgears Market is Expected to Reach USD 2,184.62 million by 2032 | Cre …
The Medical Headgears Market is poised for substantial growth, with a market value of USD 1,247.86 million in 2024 projected to surge to USD 2,184.62 million by 2032, representing a robust compound annual growth rate (CAGR) of 6.36%.
In the realm of healthcare, innovation is key, and this holds true for the field of medical headgears. These devices play a crucial role in various medical applications, from orthodontics to craniofacial…

Quality Management Software Market Size, Share, Analysis, Growth & Forecast 2030
The latest market report published by Credence Research, Inc. The global demand for Quality Management Software market was valued at USD 9654.8 Million in 2023 and is expected to reach USD 24697.3 Million in 2032, growing at a CAGR of 11.00% between 2024 and 2032.
In today's fast-paced and highly competitive business landscape, ensuring the highest level of product or service quality is paramount. Quality management is not just a goal…

Commercial Drone Market Size, Growth to Reach USD 56756.3 Million by 2030 | Cred …
The latest market report published by Credence Research, Inc. The global demand for Commercial Drone was valued at USD 19482.5 Million in 2022 and is expected to reach USD 56756.3 Million in 2030, growing at a CAGR of 14.30% between 2023 and 2030.
In recent years, the commercial drone market has experienced exponential growth, revolutionizing industries and opening up new possibilities for businesses across the globe. From agriculture and construction to…
More Releases for CSF
G Csf And G Csf Biosimilars Market Size Trends and Forecast by Application, Type …
USA, New Jersey- According to Market Research Intellect, the global G Csf And G Csf Biosimilars market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The G-CSF and G-CSF biosimilars market is witnessing steady growth, largely due to increasing demand for affordable treatments for neutropenia, especially…
G-CSF & G-CSF Biosimilars Market Growth 2032: Increasing Cancer Treatment Demand …
The global market for Granulocyte Colony Stimulating Factor (G-CSF) and G-CSF biosimilars is on a promising growth trajectory as the demand for cost-effective and therapeutic alternatives to branded drugs increases. G-CSF and its biosimilars are vital in treating neutropenia, leukopenia, platelet disorders, and various types of cancer, and their growing adoption is fueled by technological advancements and supportive government policies.
The market size was valued at $5.89 billion USD in 2023…
G-CSF and G-CSF Biosimilars Market Size, Growth and Forecast 2021 to 2028 By Ame …
The worldwide G-CSF and G-CSF Biosimilars market report is the very much investigated answer for the chiefs and academicians who are looking for a definite examination regarding both subjective just as quantitative, for the notable time frame and for the impending years gauge. The exploration report includes the business outline alongside the approaching dangers and supporting components that will drive or hamper the market development and give open doors sooner…
G-CSF and G-CSF Biosimilars Market Size to Witness Huge Growth by 2027: Pfizer, …
G-CSF and G-CSF Biosimilars market Research Report
LOS ANGELES, United States: QY Research offers an overarching research and analysis-based study on, “Global G-CSF and G-CSF Biosimilars Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application“. This report offers an insightful take on the drivers and restraints present in the market. G-CSF and G-CSF Biosimilars data reports also provide a 5 year pre-historic and forecast…
Global G-CSF And G-CSF Biosimilars Market 2025| By Top Key Players Pfizer, Novar …
G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimulate mobilization of haematopoietic stem cells for collection and transplantation.
Request Sample Copy of Report @ https://www.researchtrades.com/request-sample/1664081
This report studies…
China CSF Management Market Outlook to 2023
New report, "China CSF Management Market Outlook to 2023", provides key market data on theChina CSF Management market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Hydrocephalus Shunts and Dura Substitutes.
The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on…